Institutional resources for training. The School of Medicine at the University of North Carolina at Chapel Hill has many resources that support the training of individuals in translational research. It offers a four-year curriculum for more than 160 entering students pursuing the M.D. degree and also offers admission to twelve M.D/Ph.D. entering students annually. Graduate doctoral programs (Ph.D.) are offered in all the basic sciences departments, as are vigorous post-doctoral training programs in both the basic science and clinical departments. Of note, UNC is blessed with a host of multidisciplinary research centers, institutes, and programs, which promote interactions between basic scientists and clinicians. This combination of departmental and research center based programs has been responsible for the training of a large number of individuals in both the basic sciences and clinical investigation over the years. Currently, 46 NIH-sponsored training programs are active on the School of Medicine campus. An additional ten training programs are funded by non-NIH sources including the prestigious Markey Training Program which is jointly supported by the State of North Carolina and the Markey Foundation to provide graduate student stipends for students training in the Genetics Curriculum who wish to train in gene therapy. Many of these centers and programs are attractive for the recruitment of individuals interested in translational gene transfer research. Key centers and programs relevant to our efforts include the Caviness General Clinical Research Center (GCRC), the Cystic Fibrosis/Pulmonary Research and Treatment Center, the Gene Therapy Center, the M.D./Ph.D. program, the Center for Thrombosis and Hemostasis, the Lineberger Comprehensive Cancer Center, the Neuroscience Center, the Curriculum in Genetics and Molecular Biology, and the Program in Molecular Biology and Biotechnology. The Cystic Fibrosis/Pulmonary Research and Treatment Center and the Gene Therapy Center each have active training programs that would be enhanced by this MTCC application. A list of current trainees for these two centers is included in Table 1. The Caviness General Clinical Research Center (GCRC) is of special importance to trainees interested in translational research. This NIH-funded center is directed by Dr. Paul B. Watkins and houses six patient rooms designed for gene therapy protocols employing recombinant gene transfer vectors. Significant support is available to trainees through the GCRC including a biostatistician and computer systems analyst to assist with data collection and analysis, nursing support for clinical trials, an office of clinical trials for assistance with protocol design and institutional review board (IRB) review, a core laboratory for processing of routine human laboratory specimens from clinical trials, and a human applications laboratory for processing of molecular specimens from human trials and ultimately vector production. Although not yet official, we anticipate that the GCRC will transition into a Clinical and Translational Science Award (CTSA) in this budgetary year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK065988-06
Application #
7688330
Study Section
Special Emphasis Panel (ZDK1-GRB-1 (J2))
Project Start
2009-04-01
Project End
2014-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
6
Fiscal Year
2009
Total Cost
$2
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Polineni, Deepika; Dang, Hong; Gallins, Paul J et al. (2018) Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity. Am J Respir Crit Care Med 197:79-93
Abdullah, Lubna H; Coakley, Raymond; Webster, Megan J et al. (2018) Mucin Production and Hydration Responses to Mucopurulent Materials in Normal versus Cystic Fibrosis Airway Epithelia. Am J Respir Crit Care Med 197:481-491
Duncan, Gregg A; Kim, Namho; Colon-Cortes, Yanerys et al. (2018) An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy. Mol Ther Methods Clin Dev 9:296-304
Gentzsch, Martina; Mall, Marcus A (2018) Ion Channel Modulators in Cystic Fibrosis. Chest 154:383-393
Terryah, Shawn T; Fellner, Robert C; Ahmad, Saira et al. (2018) Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease. Am J Physiol Lung Cell Mol Physiol 314:L192-L205
Gillen, Austin E; Yang, Rui; Cotton, Calvin U et al. (2018) Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. J Cyst Fibros 17:444-453
Muhlebach, Marianne S; Zorn, Bryan T; Esther, Charles R et al. (2018) Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children. PLoS Pathog 14:e1006798
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Porrello, Alessandro; Leslie, Patrick L; Harrison, Emily B et al. (2018) Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nat Commun 9:1988
Trimble, Aaron T; Whitney Brown, A; Laube, Beth L et al. (2018) Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis. J Cyst Fibros 17:650-656

Showing the most recent 10 out of 133 publications